L3Harris Technologies enters its May 11 Q1 2026 earnings report nursing a 16% one-month loss and with its RSI at just 24 — the most technically oversold the stock has been in a long time. The question for investors is whether the selloff has created a buying opportunity or whether the print confirms the deterioration.
Options traders have turned decisively more defensive into the report. The put/call ratio hit 0.52 on Thursday, more than two standard deviations above its 20-day mean of 0.44 — the most elevated hedging posture in at least several months. That tells a clear story: even with LHX down sharply on the month, investors are paying for downside protection rather than leaning into a bounce. The stock closed at $301.18, down 6% on the week and well off its March highs above $370.
Short interest is not the headline here. At 1.3% of the free float, the short position is too modest to drive the narrative. It has risen roughly 32% over the past month in share terms — a notable build — but in absolute terms it remains a small fraction of the float, with borrow availability running at an enormous 8,754% of short interest. Borrow cost is also negligible at 0.48% APR. There is no meaningful squeeze pressure, and short sellers are not the reason the stock has fallen.
The real debate sits between two camps that have diverged sharply in recent weeks. The bull case centres on execution: the Aerojet segment was delivering 12% organic sales growth and robust free cash flow, with FY25 FCF guidance raised by $200 million to $2.65 billion — 9% above consensus at the time. Bulls also point to raised revenue guidance across the Integrated Mission Systems and Space & Airborne Systems divisions. The bear case flags the SAS operating margin slipping 30 basis points year-on-year to 12.3%, budget timing risks, and softness in the Space segment that management acknowledged openly. That bull/bear framing dates from early January 2026, but the month-long selloff — steeper than any of LHX's close peers — suggests the market has been repricing toward the bearish reading. Peers RTX and LMT each fell less than 1% on the week; HII and KRMN dropped harder, down 14% and 11% respectively, hinting at broader sector pressure on defence names rather than LHX-specific idiosyncratic risk.
On the analyst side, recent moves tilt cautious. Bernstein's Douglas Harned trimmed his target from $435 to $405 last week while holding Outperform — a signal of reduced conviction without abandoning the long. UBS kept its Neutral rating but cut its target from $362 to $330. The Street consensus mean target of $384 implies roughly 27% return potential from current levels, yet both target cuts point in the same direction. Insider activity offers little counterweight: the most recent trades of note have been sales, including a $6.7 million disposal by CEO Christopher Kubasik in February at $355.
The earnings call on May 11 is therefore less about whether LHX is growing and more about whether management can demonstrate that margin pressure in SAS is transient, that the FCF raise was not a one-off, and that Space-segment headwinds are contained — with a stock already priced for considerable doubt.
See the live data behind this article on ORTEX.
Open LHX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
